Search Within

Andrew D Zelenetz

  1. "Maria Palomba"
Formats
  1. Meeting Abstract (86)
  2. Journal Article (36)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (126)
  2. Department of Medicine (126)
  3. Hematologic Malignancies, Division of (126)
  4. Lymphoma (126)
  5. Population Sciences Research Program (98)
  6. Survivorship Research (95)

More Groups

People
  1. Maria Palomba (126)
  2. Ariela Noy (106)
  3. Paul Hamlin (103)
  4. Steven Horwitz (96)
  5. Alison Moskowitz (89)
  6. David Straus (88)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (15)
  6. 2020 (11)

More Years

Publications
  1. Blood (66)
  2. Journal of Clinical Oncology (12)
  3. Hematological Oncology (11)
  4. Blood Advances (8)
  5. Blood Cancer Journal (6)
  6. Haematologica (4)

More Publications

Publishers
  1. American Society of Hematology (74)
  2. American Society of Clinical Oncology (12)
  3. Wiley Blackwell (11)
  4. Nature Publishing Group (7)
  5. Ferrata Storti Foundation (4)
  6. Elsevier Inc. (3)

More Publishers

Results (126)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
    Research Letter

    Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Validation of LymphGen classification on a 400-gene clinical next-generation sequencing panel in diffuse large B-cell lymphoma: Real-world experience from a cancer center
    Research Letter

    Zhu, M. L.; Drill, E.; Joffe, E.; Salles, G.; Rivas Delgado, A.; Zelenetz, A.; Palomba, M. L.; Arcila, M.; Dogan, A.
    Haematologica (2024)

    Fulltext@MSK | Save
  • Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Journal Article

    Bantilan, K. S.; Smith, A. N.; Maurer, M. J.; Teruya-Feldstein, J.; Matasar, M. J.; Moskowitz, A. J.; Straus, D. J.; Noy, A.; Palomba, M. L.; Horwitz, S. M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation
    Meeting Abstract

    Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save